M. Scherr et al., EFFECTIVE REVERSAL OF A TRANSFORMED PHENOTYPE BY RETROVIRUS-MEDIATED TRANSFER OF A RIBOZYME DIRECTED AGAINST MUTANT N-RAS, Gene therapy, 5(9), 1998, pp. 1227-1234
A hammerhead ribozyme directed against oncogenic N-ras (N-13-ras) was
introduced into a retroviral vector and its activity evaluated in vitr
o and in cell lines. The catalytic efficiency of the ribozyme embedded
within a 2618 nucleotides in vitro-generated transcript was not signi
ficantly affected by the length of non-base pairing flanking sequences
. A sensitive assay based on N-ras/luciferase fusion transcripts as a
reporter system was used to assess ribozyme activity in mammalian cell
s. More than 95% reduction in luciferase activity was observed in cell
s transduced with a retrovirus containing the active form of the riboz
yme, whereas no significant reduction was observed with the inactive f
orm of the same ribozyme. in order to assay the activity of the retrov
irally encoded ribozyme in a biological setting, the IL-3-dependent ce
ll line TF-1 was transformed with N-13-ras. Expression of N-13-ras in
these cells induced factor-independent colony growth and a dose-depend
ent proliferative response to erythropoietin (Epo). Retrovirus-mediate
d expression of the active form of the ribozyme in these cells restore
d factor-dependent colony growth and abolished the proliferative respo
nse to Epo. The reversion of the transformed phenotype correlated with
a reduction in the amount of N-13-ras mRNA.